港股異動 | 手遊股爆發 中手遊尾盤飆漲逾20% 60款遊戲獲批可釋除市場擔憂
格隆匯6月10日丨中手遊尾盤飆漲逾20%領銜上漲,網龍、指尖悅動、金山軟件均漲超10%,IGG漲約7%,心動公司、網易皆有漲幅。日前,新一批60款國產遊戲版號下發。富瑞發表報告,指內地批60款國產網絡遊戲,可釋除市場對內地遊戲產業前景的擔憂。預計騰訊、中手遊等將成爲恢復遊戲審批的受益者。多家市場分析機構指出,隨着國內第二批60款遊戲版號的下發,較4月時發佈的45款遊戲版號更多,從而加強遊戲審批流程更加正常化的信心,市場正逐漸釋放對中國遊戲產業前景的擔憂情緒,投資者將變得更加積極。此外,內地批出60款國產網絡遊戲,亦向互聯網行業發出政策支持正面信號。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.